Nabumetone 500 Mg
NDC 0722-7076
Product Information
Nabumetone 500 Mg is a ANDA-approved product labeled by Nexgen Pharma, Inc.. This product is primarily utilized in pharmaceutical processing or compounding. It is supplied as a white product. This product entry covers the primary NDC 0722-7076 and 2 associated package configurations. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Labeler & Regulatory Data
Marketing Timeline
Product Characteristics
HT;500
Code Structure Chart
Product Details
What is NDC 0722-7076?
What are the uses of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- NABUMETONE (UNII: LW0TIW155Z)
- NABUMETONE (UNII: LW0TIW155Z) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- POVIDONE, UNSPECIFIED (UNII: FZ989GH94E)
- HYDROXYPROPYL CELLULOSE (90000 WAMW) (UNII: UKE75GEA7F)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 311892 - nabumetone 500 MG Oral Tablet
- RxCUI: 311893 - nabumetone 750 MG Oral Tablet
- RxCUI: 427726 - nabumetone 1000 MG Oral Tablet
* Please review the full disclaimer at the bottom of this page.